Web Results

www.contemporarypediatrics.com/view/triple-combination-therapy-cystic-fibrosis-here

Feb 10, 2020 ... Ivacaftor (Kalydeco): In 2012, the first modulator, ivacaftor, was approved by the US Food and Drug Administration (FDA) for the treatment of CF ...

www.crick.ac.uk/news/2020-07-10_cystic-fibrosis-drug-trialled-to-fight-inflammation-caused-by-covid-19

Jul 10, 2020 ... Patients with COVID-19 will be given the cystic fibrosis drug 'Dornase alfa' to determine if it can help improve survival by reducing excess ...

journals.lww.com/co-pulmonarymedicine/fulltext/2019/11000/prevention_of_drug_related_complications_in_cystic.16.aspx

Cystic fibrosis patients may benefit from maintenance treatment with macrolides because of their antibacterial and presumed anti-inflammatory effect.

www.nationaljewish.org/conditions/cystic-fibrosis-cf/research

Oct 1, 2019 ... 1990 - Cystic fibrosis researchers achieve "proof of concept" that gene therapy (in the laboratory) is possible. 1993 - The U.S. Food and Drug ...

www.yahoo.com/lifestyle/fda-approves-breakthrough-cystic-fibrosis-223342258.html

Oct 23, 2019 ... On Monday, the FDA announced it gave approval to a new triple-combination drug therapy, brand name Trikafta (elexacaftor/ivacaftor/tezacaftor), ...

www.sciencealert.com/fda-fast-tracks-long-awaited-cystic-fibrosis-drug-that-works-on-90-percent-of-patients

Nov 1, 2019 ... The data, being unveiled Thursday at a national conference in Tennessee and simultaneously published in two leading medical journals, was so ...

www.wsj.com/articles/vertex-gets-fda-ok-for-cystic-fibrosis-drug-1435861189

Jul 2, 2015 ... Vertex's cystic-fibrosis drug Orkambi, which treats the most common mutation of the disease, received U.S. regulatory approval on Thursday.

www.cbsnews.com/news/cystic-fibrosis-drug-kalydeco-approved-by-fda-what-does-it-mean-for-patients

Jan 31, 2012 ... November study found Kalydeco improved lung function, reduced complications in patients with cystic fibrosis who have G551D mutation.

www.newscientist.com/article/2134112-cystic-fibrosis-drug-halts-lung-damage-in-young-children

Jun 9, 2017 ... Orkambi has been approved in the US, EU and other countries, and has been shown to reduce the number of lung infections people with cystic ...

www.uab.edu/news/research/item/8312-uab-clinical-trials-pave-way-to-new-cystic-fibrosis-drug

May 15, 2017 ... According to Rowe, the new Tezacaftor/Ivacaftor combination drug is an extremely exciting development in cystic fibrosis therapy for two ...

science.sciencemag.org/content/335/6069/645

Feb 10, 2012 ... Last week, the news that U.S. regulators had approved a new drug for cystic fibrosis (CF) cheered patients and the biomedical research ...